Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Trans-lycopene is a lipophilic carotenoid and potent antioxidant primarily found in tomatoes and red fruits. Its biological activity is mediated through its interaction with specific cell-surface proteins that facilitate its uptake and modulate downstream signaling. The primary transporters for trans-lycopene are scavenger receptor class B member 1 (SR-B1) and CD36, which are responsible for its absorption in the intestines and its distribution to peripheral tissues [4, 7]. Beyond its role in lipid transport, lycopene has been shown to exert significant anti-inflammatory and anti-cancer effects by downregulating the expression of Fc gamma receptors (FcgR) on the surface of immune cells and in tissues such as the prostate [10, 11]. This modulation of Fc receptors, combined with the inhibition of proinflammatory cytokines like IL-6 and the suppression of the IGF-1 signaling pathway, contributes to the reduction of oxidative stress and the inhibition of tumor cell proliferation [1, 12]. Consequently, these receptors are key targets for the therapeutic and preventive actions of lycopene in conditions such as prostate cancer, cardiovascular disease, and age-related macular degeneration [16, 17].
Lycopene binds to cell-surface transporters SR-B1 and CD36 for cellular uptake and subsequently downregulates the expression of Fc gamma receptors and proinflammatory cytokines to exert anti-inflammatory and anti-cancer effects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Scavenger receptor class B member 1 and Fc gamma receptors (SR-B1/FcgR).